Prime Medicine, Inc. (PRME)
3.25
-0.14
(-4.13%)
USD |
NASDAQ |
Aug 24, 16:00
3.26
+0.01
(+0.31%)
After-Hours: 20:00
Prime Medicine Price : 3.25 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 3.38 | 3.40 | 3.195 | 3.25 | 2.268M |
| Aug 21, 2026 | 3.26 | 3.49 | 3.24 | 3.39 | 3.603M |
| Aug 20, 2026 | 3.43 | 3.50 | 3.20 | 3.24 | 3.798M |
| Aug 19, 2026 | 3.29 | 3.59 | 3.25 | 3.54 | 6.791M |
| Aug 18, 2026 | 3.10 | 3.199 | 3.02 | 3.05 | 1.271M |
| Aug 17, 2026 | 3.07 | 3.19 | 3.020 | 3.17 | 1.501M |
| Aug 14, 2026 | 3.14 | 3.14 | 3.00 | 3.09 | 1.571M |
| Aug 13, 2026 | 3.23 | 3.285 | 3.13 | 3.17 | 1.889M |
| Aug 12, 2026 | 3.24 | 3.305 | 3.17 | 3.20 | 1.444M |
| Aug 11, 2026 | 3.20 | 3.29 | 3.085 | 3.26 | 2.258M |
| Aug 10, 2026 | 3.09 | 3.315 | 3.06 | 3.15 | 3.596M |
| Aug 07, 2026 | 3.00 | 3.12 | 2.97 | 3.08 | 1.977M |
| Aug 06, 2026 | 3.06 | 3.15 | 2.91 | 2.95 | 2.555M |
| Aug 05, 2026 | 2.98 | 3.12 | 2.89 | 3.08 | 3.145M |
| Aug 04, 2026 | 2.875 | 2.98 | 2.82 | 2.98 | 3.162M |
| Aug 03, 2026 | 2.91 | 2.91 | 2.72 | 2.81 | 3.953M |
| Jul 31, 2026 | 3.03 | 3.04 | 2.91 | 2.92 | 1.837M |
| Jul 30, 2026 | 3.04 | 3.14 | 2.985 | 3.02 | 2.163M |
| Jul 29, 2026 | 3.07 | 3.115 | 2.955 | 3.03 | 2.196M |
| Jul 28, 2026 | 3.00 | 3.10 | 2.865 | 3.09 | 3.097M |
| Jul 27, 2026 | 2.97 | 3.18 | 2.97 | 3.01 | 2.615M |
| Jul 24, 2026 | 3.00 | 3.03 | 2.86 | 2.95 | 2.403M |
| Jul 23, 2026 | 3.05 | 3.06 | 2.95 | 2.97 | 2.486M |
| Jul 22, 2026 | 3.11 | 3.16 | 3.04 | 3.09 | 2.182M |
| Jul 21, 2026 | 3.07 | 3.15 | 2.93 | 3.12 | 3.751M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Beam Therapeutics, Inc. | 28.33 |
| Twist Bioscience Corp. | 140.80 |
| Sana Biotechnology, Inc. | 3.78 |
| Generate Biomedicines, Inc. | 17.72 |
| Intellia Therapeutics, Inc. | 12.56 |
Price Related Metrics
| PS Ratio | 138.71 |
| Price to Book Value | 14.76 |
| Earnings Yield | -33.40% |
| Market Cap | 587.40M |